[ Price : $8.95]
FDA warns Indias Cohance Lifesciences about CGMP violations in its production of drugs at one of its manufacturing sites.[ Price : $8.95]
Three drug trade associations give FDA their perspectives on increasing access to nonprescription drugs.[ Price : $8.95]
Three Hogan Lovells attorneys analyze the new FDA medical device inspection compliance program and caution manufacturers to begin ...[ Price : $8.95]
FDA classifies Abbott Diabetes Cares recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring ...[ Price : $8.95]
Media reports say senior Trump administration officials blocked a promising new psychedelic treatment for severe depression from b...[ Price : $8.95]
President Trump signs a government spending bill that officially reinstates FDAs Rare Pediatric Disease Priority Review Voucher pr...[ Price : $8.95]
Amgen rejects an FDA request asking it to voluntarily withdraw its vasculitis drug Tavneos (avacopan) from the U.S. market due to ...[ Price : $8.95]
FDA grants AstraZeneca and Daiichi Sankyo a priority review for their antibodydrug conjugate Datroway (datopotamab deruxtecan) as ...